In one paragraphArticle in Leukemia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
20 authors.
Shinya SatoDepartment of Hematology, Nagasaki University Hospital, Nagasaki, Japan.
Makiko HoraiDepartment of Hematology, Unit for Radiation Effects on Humans, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
Akira KinoshitaDepartment of Human Genetics, Unit for Radiation Effects on Humans, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
Yotaro OchiDepartment of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Kazuhiro NagaiTransfusion and Cell Therapy Unit, Nagasaki University Hospital, Nagasaki, Japan.
Kenichi YokotaBiostatistics Section, Scientific Data and Biomaterial Center, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
Koichiro HamadaDepartment of General Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Nagasaki, Japan.
Shinichi NambaDepartment of Genome Informatics, Graduate School of Medicine, The University of Tokyo, Hongo, Tokyo, Japan.
Koichi MatsudaLaboratory of Clinical Genome Sequencing, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Shirokanedai, Tokyo, Japan.ORCID http://orcid.org/0000-0001-7292-2686 Funding
Japan Agency for Medical Research and Development (AMED) JP223fa627011Japan Agency for Medical Research and Development (AMED) JP23tm0624002Japan Agency for Medical Research and Development (AMED) JP24ama221530Japan Agency for Medical Research and Development (AMED) JP24zf0127009MEXT | Japan Society for the Promotion of Science (JSPS) 17H04209MEXT | Japan Society for the Promotion of Science (JSPS) 20H03712MEXT | Japan Society for the Promotion of Science (JSPS) 25K11628MEXT | Japan Society for the Promotion of Science (JSPS) JP18H02836MEXT | Japan Society for the Promotion of Science (JSPS) JP19H05656MEXT | Japan Society for the Promotion of Science (JSPS) JP24H00009MEXT | Japan Society for the Promotion of Science (JSPS) JP26221308Ministry of Education, Culture, Sports, Science and Technology (MEXT) hp180198Ministry of Education, Culture, Sports, Science and Technology (MEXT) hp190158Ministry of Education, Culture, Sports, Science and Technology (MEXT) hp200138
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
What OpenQuestion holds
Textmetadata
Read underepoch 390